These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. lncRNA EGFR-AS1 facilitates leiomyosarcoma progression and immune escape via the EGFR-MYC-PD-L1 axis. Chen ML; Fan L; Huang GR; Sun ZF Int Immunol; 2022 Jul; 34(7):365-377. PubMed ID: 35485964 [TBL] [Abstract][Full Text] [Related]
3. HOXA11-AS1 Promotes PD-L1-Mediated Immune Escape and Metastasis of Hypopharyngeal Carcinoma by Facilitating PTBP1 and FOSL1 Association. Zhou Z; Liu Q; Zhang G; Mohammed D; Amadou S; Tan G; Zhang X Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954358 [TBL] [Abstract][Full Text] [Related]
4. LncRNA OIP5-AS1 Knockdown Facilitated the Ferroptosis and Immune Evasion by Modulating the GPX4 in Oesophageal Carcinoma. Hou J; Huang Q; Fan Z; Sang H; Wu S; Cheng S; Li Q Comput Math Methods Med; 2022; 2022():8103198. PubMed ID: 35872956 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer. Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757 [TBL] [Abstract][Full Text] [Related]
6. CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis. Gao C; Xu YJ; Qi L; Bao YF; Zhang L; Zheng L Cell Biol Toxicol; 2022 Oct; 38(5):825-845. PubMed ID: 34018092 [TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis. Huang Y; Xia L; Tan X; Zhang J; Zeng W; Tan B; Yu X; Fang W; Yang Z Cell Mol Biol Lett; 2022 Jun; 27(1):43. PubMed ID: 35658874 [TBL] [Abstract][Full Text] [Related]
8. N Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901 [TBL] [Abstract][Full Text] [Related]
9. USP7 Enables Immune Escape of Glioma Cells by Regulating PD-L1 Expression. Li B; Wang B Immunol Invest; 2022 Oct; 51(7):1921-1937. PubMed ID: 35852892 [TBL] [Abstract][Full Text] [Related]
10. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195. Wang QM; Lian GY; Song Y; Huang YF; Gong Y Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647 [TBL] [Abstract][Full Text] [Related]
11. LncRNA FOXP4-AS1 Promotes the Progression of Esophageal Squamous Cell Carcinoma by Interacting With MLL2/H3K4me3 to Upregulate FOXP4. Niu Y; Wang G; Li Y; Guo W; Guo Y; Dong Z Front Oncol; 2021; 11():773864. PubMed ID: 34970490 [TBL] [Abstract][Full Text] [Related]
12. LncRNA FOXP4-AS promotes the progression of non-small cell lung cancer by regulating the miR-3184-5p/EIF5A axis. Li D; Li Z; YanFei W; Wang Y; Shi J; Liu C; Qu L; Deng S; Xiong D J Tissue Eng Regen Med; 2022 Apr; 16(4):335-345. PubMed ID: 34921595 [TBL] [Abstract][Full Text] [Related]
13. LncRNA PROX1 antisense RNA 1 promotes PD-L1-mediated proliferation, metastasis, and immune escape in colorectal cancer by interacting with miR-520d. Li JS; Liu TM; Li L; Jiang C Anticancer Drugs; 2023 Jun; 34(5):669-679. PubMed ID: 36730426 [TBL] [Abstract][Full Text] [Related]
14. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC. Xia Y; Wang WC; Shen WH; Xu K; Hu YY; Han GH; Liu YB Chem Biol Interact; 2021 Nov; 349():109652. PubMed ID: 34520751 [TBL] [Abstract][Full Text] [Related]
15. E3 Ubiquitin Ligase RNF125 Suppresses Immune Escape in Head and Neck Squamous Cell Carcinoma by Regulating PD-L1 Expression. Jiang C; He L; Xiao S; Wu W; Zhao Q; Liu F Mol Biotechnol; 2023 Jun; 65(6):891-903. PubMed ID: 36344734 [TBL] [Abstract][Full Text] [Related]
16. LncRNA FOXP4-AS1 silencing inhibits metastasis and epithelial-mesenchymal transition in nasopharyngeal carcinoma via miR-136-5p/MAPK1. Yan J; Zhou Q Anticancer Drugs; 2023 Nov; 34(10):1104-1111. PubMed ID: 36961080 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA FOXP4-AS1 acts as an adverse prognostic factor and regulates proliferation and apoptosis in nasopharyngeal carcinoma. Zhong LK; Zhou J; He X; He BF; Zhou XW; Zhu JL; Liu J; Qiu YH Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8008-8016. PubMed ID: 32767327 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA FOXP4-AS1 is a prognostic biomarker and associated with immune infiltrates in ovarian serous cystadenocarcinoma. Liao C; Wang A; Ma Y; Liu H Medicine (Baltimore); 2021 Oct; 100(40):e27473. PubMed ID: 34622876 [TBL] [Abstract][Full Text] [Related]
19. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis. Zhang H; Zhu C; He Z; Chen S; Li L; Sun C J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166 [TBL] [Abstract][Full Text] [Related]
20. LncRNA FOXP4-AS1 Promotes Progression of Ewing Sarcoma and Is Associated With Immune Infiltrates. Xiong J; Wu L; Huang L; Wu C; Liu Z; Deng W; Ma S; Zhou Z; Yu H; Cao K Front Oncol; 2021; 11():718876. PubMed ID: 34765540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]